US$ 24.21
exendin 4 vs glp 1 Genetic engineering of novel super long-acting Exendin-4 chimeric protein for effective treatment of metabolic and cognitive complications of obesity In vitro and in vivo
Description
Hegeds L, Sherman SI, Tuttle RM, et al
12 , 14 , 18 , 24 While these exclusions help reduce confounding, they do not eliminate it entirely, and attributing the observed findings solely to GLP-1 RA use remains open to debate

and Verma, S

Wang Z, Saha S, Van Horn S, Thomas E, Traini C, Sathe G, et al

The effect of liraglutide on endothelial function in patients with type 2 diabetes

What happened to the prior 9-month guarantee
